Cantor SPAC Seeks $200M IPO, Flags Dilution & Conflicts

TL;DR

**Avoid this SPAC; the sponsor's $0.004 per share entry and significant fees create too much dilution and conflict for public investors.**

AI Summary

Cantor Equity Partners V, Inc. (CEPV) filed an S-1/A for an initial public offering of 20,000,000 Class A ordinary shares at $10.00 per share, aiming to raise $200,000,000. The company is a blank check company, or SPAC, with no specific business combination target identified yet. Its sponsor, Cantor EP Holdings V, LLC, purchased 5,750,000 Class B ordinary shares for a nominal $25,000, or approximately $0.004 per share, and will also purchase 500,000 Class A ordinary shares for $5,000,000 in a private placement. Public shareholders face immediate and substantial dilution due to the sponsor's low-cost founder shares and potential anti-dilution adjustments. The company has 24 months from the offering's closing to complete a business combination, or it will redeem public shares at $10.00 per share. Significant conflicts of interest exist due to the sponsor's and management's affiliations with Cantor Fitzgerald & Co., which will receive a $4,000,000 underwriting discount and a $7,000,000 business combination marketing fee.

Why It Matters

This S-1/A filing reveals Cantor Equity Partners V, Inc.'s intent to raise $200 million as a blank check company, presenting a speculative investment for investors. The significant dilution from the sponsor's $0.004 per share founder shares, coupled with potential conflicts of interest involving Cantor Fitzgerald & Co.'s fees, could erode investor returns. For employees and customers of a future target, the SPAC structure introduces uncertainty regarding post-acquisition strategy and stability. In the competitive SPAC market, these terms highlight the ongoing challenges for public shareholders to find value amidst sponsor-friendly structures.

Risk Assessment

Risk Level: high — The risk level is high due to the substantial dilution public shareholders will incur from the sponsor's purchase of 5,750,000 Class B ordinary shares for only $25,000 (approximately $0.004 per share). This creates a strong incentive for the sponsor to complete any transaction, even if unprofitable for public shareholders. Additionally, significant conflicts of interest exist, with Cantor Fitzgerald & Co. set to receive a $4,000,000 underwriting discount and a $7,000,000 business combination marketing fee, potentially influencing target selection.

Analyst Insight

Investors should exercise extreme caution and thoroughly evaluate the significant dilution and conflicts of interest outlined in this S-1/A. Given the sponsor's nominal cost basis and substantial fees to affiliates, it would be prudent to wait for a definitive business combination target and assess its merits independently before considering an investment.

Financial Highlights

debt To Equity

0.0

revenue

$0

operating Margin

N/A

total Assets

$0

total Debt

$0

net Income

$0

eps

$0.00

gross Margin

N/A

cash Position

$0

revenue Growth

N/A

Key Numbers

• $200,000,000 — Target IPO proceeds (Amount to be raised from the offering of 20,000,000 Class A ordinary shares at $10.00 per share.)
• $10.00 — Public offering price per share (Price for each Class A ordinary share in the initial public offering.)
• $0.004 — Sponsor's cost per founder share (The price Cantor EP Holdings V, LLC paid for each of its 5,750,000 Class B ordinary shares, creating significant dilution.)
• 24 months — Time to complete business combination (The period Cantor Equity Partners V, Inc. has to consummate an initial business combination from the closing of the offering.)
• $4,000,000 — Underwriting discount (Fee payable to Cantor Fitzgerald & Co. upon the closing of this offering.)
• $7,000,000 — Business combination marketing fee (Fee payable to Cantor Fitzgerald & Co. upon the closing of the initial business combination.)
• 5,750,000 — Class B ordinary shares held by sponsor (Number of founder shares purchased by Cantor EP Holdings V, LLC for $25,000.)
• 500,000 — Private placement Class A ordinary shares (Number of Class A ordinary shares Cantor EP Holdings V, LLC will purchase for $5,000,000.)
• 20% — Founder shares ownership percentage (The percentage of issued and outstanding ordinary shares the founder shares will represent upon consummation of this offering (excluding private placement shares).)
• $300,000 — Loan repayment to sponsor (Maximum amount of loans made by the sponsor to be repaid upon consummation of the offering for offering-related and organizational expenses.)

Key Players & Entities

• Cantor Equity Partners V, Inc. (company) — Registrant for S-1/A filing
• Cantor EP Holdings V, LLC (company) — Sponsor of Cantor Equity Partners V, Inc.
• Brandon Lutnick (person) — Chief Executive Officer of Cantor Equity Partners V, Inc.
• Douglas S. Ellenoff, Esq. (person) — Counsel from Ellenoff Grossman & Schole LLP
• Stuart Neuhauser, Esq. (person) — Counsel from Ellenoff Grossman & Schole LLP
• David Alan Miller, Esq. (person) — Counsel from Graubard Miller
• Jeffrey M. Gallant, Esq. (person) — Counsel from Graubard Miller
• Cantor Fitzgerald & Co. (company) — Affiliate of sponsor and underwriter
• U.S. Securities and Exchange Commission (regulator) — Regulatory body for S-1/A filing
• Nasdaq Global Market (company) — Intended listing exchange for CEPV Class A ordinary shares

FAQ

Risk Factors

• Dilution from Sponsor Shares and Private Placement [high — financial]: The sponsor, Cantor EP Holdings V, LLC, acquired 5,750,000 Class B ordinary shares for $25,000 ($0.004 per share) and will purchase 500,000 Class A shares for $5,000,000. This structure, especially the low cost of founder shares, creates significant immediate dilution for public shareholders upon the IPO, potentially exacerbated by anti-dilution adjustments.
• Dependence on Business Combination Target [high — financial]: As a blank check company, CEPV has no identified target for its business combination. The success of the IPO and the company's future value are entirely dependent on identifying and consummating a suitable acquisition within the 24-month timeframe, failing which public shareholders will face redemption at $10.00 per share.
• Conflicts of Interest with Sponsor and Underwriter [high — financial]: The sponsor and management's affiliations with Cantor Fitzgerald & Co. present conflicts of interest. Cantor Fitzgerald will earn substantial fees, including a $4,000,000 underwriting discount and a $7,000,000 business combination marketing fee, potentially influencing deal selection and terms.
• Limited Operating History and No Business Operations [medium — regulatory]: CEPV is a newly incorporated entity with no operating history or business operations. Its ability to generate revenue or profit is entirely contingent on the successful completion of a business combination, introducing substantial uncertainty.
• Redemption Risk [medium — financial]: If CEPV fails to complete a business combination within 24 months, public shareholders will have their shares redeemed at $10.00 per share. This redemption feature limits potential upside for investors if a suitable target is not found or if market conditions deteriorate.
• Management Team's Experience in SPACs [low — operational]: While management has financial expertise, their specific experience in successfully executing SPAC mergers and integrating acquired businesses is not detailed, posing an operational risk.

Industry Context

The Special Purpose Acquisition Company (SPAC) market has seen significant activity, driven by a desire for alternative routes to public markets. However, increased regulatory scrutiny and a higher failure rate for post-merger companies are creating headwinds. Investors are becoming more discerning, focusing on experienced management teams and clear value propositions in target acquisitions.

Regulatory Implications

SPACs face evolving regulatory landscapes, including increased SEC oversight regarding disclosures, projections, and potential conflicts of interest. Compliance with securities laws and exchange listing requirements is critical, with potential penalties for non-compliance.

What Investors Should Do

1. Assess sponsor's track record and alignment of interests.
2. Evaluate the potential for dilution.
3. Consider the 24-month deadline and redemption feature.
4. Monitor the target identification and due diligence process.

Glossary

Blank Check Company (SPAC)

A shell company that is established to raise capital through an initial public offering (IPO) for the purpose of acquiring an existing company. SPACs do not have an existing business operation and are formed solely to raise money. (CEPV is a blank check company, meaning its primary purpose is to find and merge with another company, and its financial performance is tied to the success of this future acquisition.)

Class A Ordinary Shares

The class of shares offered to the public in the IPO. These shares typically carry voting rights and are entitled to dividends if declared. (These are the shares investors are purchasing in the IPO at $10.00 per share.)

Class B Ordinary Shares

Shares typically held by the sponsor or founders of a SPAC. These shares often have different voting rights or conversion features and are acquired at a nominal cost. (The sponsor's 5,750,000 Class B shares were acquired at a nominal cost, leading to significant dilution for public shareholders.)

Sponsor

The entity that organizes and finances a SPAC, typically purchasing founder shares at a low price and often participating in a private placement. (Cantor EP Holdings V, LLC is the sponsor of CEPV and benefits from the low cost of its founder shares and potential future gains.)

Underwriting Discount

A fee paid by the issuer to the underwriter(s) for their services in marketing and selling the securities in an IPO. (Cantor Fitzgerald & Co. will receive a $4,000,000 underwriting discount for its role in the IPO.)

Business Combination Marketing Fee

A fee paid to the underwriter upon the successful completion of a business combination by the SPAC. (Cantor Fitzgerald & Co. is set to receive a $7,000,000 fee upon CEPV's completion of a business combination.)

Redemption

The right of public shareholders to have their shares repurchased by the SPAC at a specified price (typically the IPO price) if a business combination is not completed within a set timeframe. (Public shareholders can redeem their shares at $10.00 if CEPV does not complete a business combination within 24 months.)

Anti-dilution Adjustments

Provisions in a SPAC's structure that protect the sponsor's investment by adjusting the number of founder shares or their conversion price in certain scenarios, often at the expense of public shareholders. (These adjustments can further increase the dilution experienced by public shareholders from the sponsor's low-cost founder shares.)

Year-Over-Year Comparison

This is the initial S-1/A filing for Cantor Equity Partners V, Inc., therefore, there are no prior filings to compare financial metrics against. Key metrics such as revenue, net income, and margins are not applicable at this pre-IPO stage. New risks introduced in this filing relate to the structure of the IPO, including sponsor dilution, potential conflicts of interest with Cantor Fitzgerald, and the inherent risks of a blank check company seeking a business combination.

Key Financial Figures

• $10.00 — s of Cantor Equity Partners V, Inc. for $10.00 per share. This Registration Statement
• $25,000 — tors — Our sponsor paid an aggregate of $25,000 for the founder shares, or approximatel
• $0.004 — or the founder shares, or approximately $0.004 per founder share, and, accordingly, yo
• $200,000,000 — COMPLETION, DATED SEPTEMBER 22, 2025 $200,000,000 Cantor Equity Partners V, Inc. 20,0
• $10,000 — tionally, we will reimburse our sponsor $10,000 per month for office space, administrat
• $50,000 — sh fees to our independent directors of $50,000 per year, payable quarterly, each as de
• $300,000 — n of this offering, we will repay up to $300,000 in loans made to us by our sponsor to c
• $1,750,000 — we will be obligated to repay the up to $1,750,000 loan commitment made by our sponsor for
• $4,000,000 — to receive an underwriting discount of $4,000,000 upon the closing of this offering, a bu
• $7,000,000 — a business combination marketing fee of $7,000,000 upon the closing of our initial busines
• $8,650,000 — initial business combination (or up to $8,650,000 if the underwriters' over -allotment op
• $230,000,000 — ivate placement shares, $200,000,000 or $230,000,000 if the underwriters' over -allotment op
• $1,000,000 — & Trust Company acting as trustee, and $1,000,000, together with $1,750,000 of additional

Filing Documents

• ea0253055-02.htm (S-1/A) — 5150KB
• ea025305502ex1-1_cantor5.htm (EX-1.1) — 230KB
• ea025305502ex1-2_cantor5.htm (EX-1.2) — 42KB
• ea025305502ex3-1_cantor5.htm (EX-3.1) — 226KB
• ea025305502ex3-2_cantor5.htm (EX-3.2) — 301KB
• ea025305502ex4-1_cantor5.htm (EX-4.1) — 18KB
• ea025305502ex5-1_cantor5.htm (EX-5.1) — 54KB
• ea025305502ex10-1_cantor5.htm (EX-10.1) — 48KB
• ea025305502ex10-2_cantor5.htm (EX-10.2) — 21KB
• ea025305502ex10-3_cantor5.htm (EX-10.3) — 41KB
• ea025305502ex10-4_cantor5.htm (EX-10.4) — 85KB
• ea025305502ex10-5_cantor5.htm (EX-10.5) — 99KB
• ea025305502ex10-6_cantor5.htm (EX-10.6) — 52KB
• ea025305502ex10-7_cantor5.htm (EX-10.7) — 138KB
• ea025305502ex10-8_cantor5.htm (EX-10.8) — 43KB
• ea025305502ex10-9_cantor5.htm (EX-10.9) — 13KB
• ea025305502ex14_cantor5.htm (EX-14) — 61KB
• ea025305502ex23-1_cantor5.htm (EX-23.1) — 2KB
• ea025305502ex99-1_cantor5.htm (EX-99.1) — 94KB
• ea025305502ex99-2_cantor5.htm (EX-99.2) — 35KB
• ea025305502ex99-4_cantor5.htm (EX-99.4) — 3KB
• ex5-1_001.jpg (GRAPHIC) — 9KB
• ex5-1_002.jpg (GRAPHIC) — 4KB
• 0001213900-25-090165.txt ( ) — 10792KB
• ck0002034266-20250922.xsd (EX-101.SCH) — 10KB
• ck0002034266-20250922_def.xml (EX-101.DEF) — 16KB
• ck0002034266-20250922_lab.xml (EX-101.LAB) — 121KB
• ck0002034266-20250922_pre.xml (EX-101.PRE) — 73KB
• ea0253055-02_htm.xml (XML) — 1315KB

Risk Factors

Risk Factors 43 Cautionary Note Regarding Forward-Looking Statements 90

Use of Proceeds

Use of Proceeds 92 Dividend Policy 96

Dilution

Dilution 97 Capitalization 99

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 100 Proposed Business 107 Management 139 Principal Shareholders 151 Certain Relationships and Related Party Transactions 154

Description of Securities

Description of Securities 158 Taxation 173 Underwriting (Conflicts of Interest) 182 Legal Matters 192 Experts 192 Where You Can Find Additional Information 192 Index to Financial Statements F-1 We are responsible for the information contained in this prospectus. We have not authorized anyone to provide you with different information, and we take no responsibility for any other information others may give to you. We are not, and the underwriters are not, making an offer to sell securities in any jurisdiction where the offer or sale is not permitted. You should not assume that the information contained in this prospectus is accurate as of any date other than the date on the front of this prospectus. Trademarks This prospectus contains references to trademarks and service marks belonging to other entities. Solely for convenience, trademarks and trade names referred to in this prospectus may appear without the or symbols, but such references are not intended to indicate, in any way, that the applicable licensor will not assert, to the fullest extent under applicable law, its rights to these trademarks and trade names. We do not intend our use or display of other companies' trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of us by, any other companies. i Table of Contents SUMMARY This summary only highlights the more detailed information appearing elsewhere in this prospectus. You should read this entire prospectus carefully, including the information under the section of this prospectus entitled "Risk Factors" and our financial statements and the related notes included elsewhere in this prospectus, before investing. Unless otherwise stated in this prospectus, or the context otherwise requires, references to: " amended and restated memorandum and articles of association " are to the amended and restated memorandum and articles of association that we will adopt prior to the consummation

View Full Filing

View this S-1/A filing on SEC EDGAR